Prognostic factors in chronic subdural hematoma: results from a monocentric consecutive surgical series of 605 patients.


Journal

Journal of neurosurgical sciences
ISSN: 1827-1855
Titre abrégé: J Neurosurg Sci
Pays: Italy
ID NLM: 0432557

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 30 9 2017
medline: 18 9 2021
entrez: 30 9 2017
Statut: ppublish

Résumé

The study of age-related diseases like chronic subdural hematoma (CSDH) is of high interest, considered the general ageing of the population. This investigation aimed to identify the main clinical characteristics of CSDH patients, to evaluate the impact of the disease on quality of life, its treatment and comorbidities/complications and to compare our data with other surgical series published over the past 5 years. A retrospective cohort study including all consecutive patients operated for CSDH between January 1, 2006 and December 31, 2013 at the Unit of Neurosurgery of our hospital was carried out. 605 patients were included in the study (66.0% male, mean age 77.5±10.5 years). History of brain trauma was reported in 65.6%. Common comorbidities were hypertension (59.0%), cardiopathies (36.0%), and previous stroke (23.6%). Clotting and coagulation alterations were present in 27.2% and 17.0%, respectively. In 24.0% of cases, the hematoma was bilateral. 17.3% had more than one surgery. Length of stay was of 14.8±10.1 days. Baseline Karnofsky Performance Score (KPS), presurgical KPS, and KPS at discharge were 87.7±14.9, 64.9 ±19.8 and 76.7±27.2, respectively. A complete recovery was observed in 62.9% of patients. Mortality rate during hospitalization was 7.4%. The knowledge of clinical and surgical factors which might impact on the clinical outcomes could help to better manage patients with CSDH, which represents a surgically "simple" but, indeed, not trivial disease.

Sections du résumé

BACKGROUND BACKGROUND
The study of age-related diseases like chronic subdural hematoma (CSDH) is of high interest, considered the general ageing of the population. This investigation aimed to identify the main clinical characteristics of CSDH patients, to evaluate the impact of the disease on quality of life, its treatment and comorbidities/complications and to compare our data with other surgical series published over the past 5 years.
METHODS METHODS
A retrospective cohort study including all consecutive patients operated for CSDH between January 1, 2006 and December 31, 2013 at the Unit of Neurosurgery of our hospital was carried out.
RESULTS RESULTS
605 patients were included in the study (66.0% male, mean age 77.5±10.5 years). History of brain trauma was reported in 65.6%. Common comorbidities were hypertension (59.0%), cardiopathies (36.0%), and previous stroke (23.6%). Clotting and coagulation alterations were present in 27.2% and 17.0%, respectively. In 24.0% of cases, the hematoma was bilateral. 17.3% had more than one surgery. Length of stay was of 14.8±10.1 days. Baseline Karnofsky Performance Score (KPS), presurgical KPS, and KPS at discharge were 87.7±14.9, 64.9 ±19.8 and 76.7±27.2, respectively. A complete recovery was observed in 62.9% of patients. Mortality rate during hospitalization was 7.4%.
CONCLUSIONS CONCLUSIONS
The knowledge of clinical and surgical factors which might impact on the clinical outcomes could help to better manage patients with CSDH, which represents a surgically "simple" but, indeed, not trivial disease.

Identifiants

pubmed: 28959873
pii: S0390-5616.17.04103-0
doi: 10.23736/S0390-5616.17.04103-0
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

14-23

Auteurs

Susanna Bacigaluppi (S)

Unit of Neurosurgery, Department of Neurosciences (DINOGMI), IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy - susannabacigaluppi@yahoo.it.
Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy - susannabacigaluppi@yahoo.it.

Fedra Guastalli (F)

Unit of Neurosurgery, Department of Neurosciences (DINOGMI), IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy.

Nicola L Bragazzi (NL)

Department of Health Sciences (DISSAL), School of Public Health, University of Genoa, Genoa, Italy.

Alberto Balestrino (A)

Unit of Neurosurgery, Department of Neurosciences (DINOGMI), IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy.

Paolo Bruzzi (P)

Unit of Clinical Epidemiology, IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy.

Gianluigi Zona (G)

Unit of Neurosurgery, Department of Neurosciences (DINOGMI), IRCCS San Martino University Hospital, University of Genoa, Genoa, Italy.
Center of Excellence for Biomedical Research (CEBR), University of Genoa, Genoa, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH